loading
前日終値:
$2.12
開ける:
$2.14
24時間の取引高:
1.06M
Relative Volume:
0.74
時価総額:
$97.10M
収益:
-
当期純損益:
$-97.22M
株価収益率:
-1.587
EPS:
-1.38
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
+8.96%
1か月 パフォーマンス:
+45.03%
6か月 パフォーマンス:
-31.99%
1年 パフォーマンス:
-89.02%
1日の値動き範囲:
Value
$2.1308
$2.2684
1週間の範囲:
Value
$2.03
$2.2684
52週間の値動き範囲:
Value
$1.15
$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name
名前
Cassava Sciences Inc
Name
セクター
Healthcare (1170)
Name
電話
512-501-2444
Name
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Name
職員
30
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
SAVA's Discussions on Twitter

SAVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SAVA
Cassava Sciences Inc
2.19 97.10M 0 -97.22M -82.44M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-26 ダウングレード H.C. Wainwright Buy → Neutral
2024-10-08 アップグレード H.C. Wainwright Neutral → Buy
2024-07-01 ダウングレード H.C. Wainwright Buy → Neutral
2022-11-16 ダウングレード B. Riley Securities Buy → Neutral
2021-07-15 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-07-07 繰り返されました Maxim Group Buy
2021-04-27 開始されました B. Riley Securities Buy
2021-02-16 繰り返されました H.C. Wainwright Buy
2020-10-23 開始されました Cantor Fitzgerald Overweight
2020-09-23 アップグレード H.C. Wainwright Neutral → Buy
2020-05-18 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-15 ダウングレード Maxim Group Buy → Hold
2020-01-10 繰り返されました Maxim Group Buy
すべてを表示

Cassava Sciences Inc (SAVA) 最新ニュース

pulisher
Jun 06, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - ACCESS Newswire

Jun 06, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Buys 55,813 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

May 31, 2025
pulisher
May 28, 2025

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Cassava Sciences Holds 2025 Annual Meeting, Elects Directors - TipRanks

May 27, 2025
pulisher
May 23, 2025

Transcript : Cassava Sciences, Inc.Shareholder/Analyst Call - marketscreener.com

May 23, 2025
pulisher
May 14, 2025

Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSAVA - ACCESS Newswire

May 14, 2025
pulisher
May 12, 2025

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Shareholders of Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Cassava Reports Q1 2025 Financials Results, Provides Business Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Cassava Sciences Shifts Focus to TSC-Related Epilepsy - TipRanks

May 09, 2025
pulisher
May 08, 2025

Cassava Sciences (SAVA) Faces Financial Challenges Amid Strategic Shifts - GuruFocus

May 08, 2025
pulisher
May 06, 2025

Invesco Ltd. Trims Stock Position in Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

May 06, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Cassava Sciences (SAVA) Appoints New SVP of Neuroscience | SAVA Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC - citybiz

May 01, 2025
pulisher
Apr 27, 2025

Investors who Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky About Pending Class ActionSAVA - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Apr 26, 2025

Cassava Sciences Inc (SAVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Cassava Sciences Inc (SAVA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Schoen Eric
Chief Financial Officer
Nov 29 '24
Option Exercise
1.18
50,000
59,000
71,300
Schoen Eric
Chief Financial Officer
Nov 29 '24
Sale
3.86
59,800
230,828
11,500
Schoen Eric
Chief Financial Officer
Nov 29 '24
Sale
3.82
2,000
7,640
0
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):